Silver Book Fact

An oral cannabinoid was found effective in relieving diabetic peripheral neuropathic pain symptoms and improving disturbed sleep, quality of life, and overall patient status.

Toth C, Mawani S, Brady S, Chan C, et al. An Enriched-Enrollment, Randomized Withdrawal, Flexible-Dose, Double-Blind, Placebo-Controlled, Parallel Assignment Efficacy Study of Nabilone as Adjuvant in the Treatment of Diabetic Peripheral Neuropathic Pain. Pain. 2012; 153(10): 2073-82. http://journals.lww.com/pain/Abstract/2012/10000/An_enriched_enrolment,_randomized_withdrawal,.16.aspx

Reference

Title
An Enriched-Enrollment, Randomized Withdrawal, Flexible-Dose, Double-Blind, Placebo-Controlled, Parallel Assignment Efficacy Study of Nabilone as Adjuvant in the Treatment of Diabetic Peripheral Neuropathic Pain
Publication
Pain
Publication Date
2012
Authors
Toth C, Mawani S, Brady S, Chan C, et al
Volume & Issue
Volume 153, Issue 10
Pages
2073-82
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Nerve growth factor (NGF) has been found to be a major mediator of inflammatory and neuropathic pain and provides a new therapeutic target.  
  • The use of sodium oxybate (SXB) in fibromylagia patients reduced pain by 30% or more in 54-58% of patients (versus 35.2% for placebo). SXB also reduced fatigue and sleep disturbance.  
  • Topical NSAIDs were found in a meta-analysis to be significantly more effective than placebo in reducing persistent pain from musculoskeletal conditions.  
  • A biopsychosocial approach (i.e., one that takes into account physical, emotional, and environmental factors in the assessment and treatment of pain) has been found to improve the pain care of…  
  • 60% of people with persistent back pain who turned to complementary and alternative medicine perceived a “”great deal”” of benefit.